Abstract |
Because the histopathological features of some primary adenocarcinomas of the sinonasal tract may show considerable overlap, we assessed the diagnostic value of a panel of immunohistochemical markers in the distinction between these malignancies. Paraffin-embedded tumour tissue sections from a series of 39 primary adenocarcinomas of the sinonasal tract, including 25 cases of intestinal-type adenocarcinoma (ITAC), 10 cases of salivary gland-type carcinoma and 4 cases of tubulopapillary low-grade adenocarcinoma were immunostained for CDX-2, cytokeratin 7 and cytokeratin 20. Diffuse nuclear staining for CDX-2 was identified in 80% of ITACs, while all non-ITACs were negative. Staining for cytokeratin 20 was positive in 84% of ITACs, including all cases negative for CDX-2, but negative in all other adenocarcinomas. Cytokeratin 7 was consistently positive in 88% of ITACs and in 100% of non-ITACs. Normal sinonasal epithelia expressed cytokeratin 7, but not CDX-2 and cytokeratin 20. Staining for CDX-2 and cytokeratin 20 has potential use in separating ITACs from other primary malignant glandular neoplasms of the nasal cavities and paranasal sinuses.
|
Authors | A Franchi, D Massi, A Palomba, M Biancalani, M Santucci |
Journal | Virchows Archiv : an international journal of pathology
(Virchows Arch)
Vol. 445
Issue 1
Pg. 63-7
(Jul 2004)
ISSN: 0945-6317 [Print] Germany |
PMID | 15175880
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- CDX2 Transcription Factor
- Homeodomain Proteins
- Intermediate Filament Proteins
- KRT20 protein, human
- KRT7 protein, human
- Keratin-20
- Keratin-7
- Trans-Activators
- Keratins
|
Topics |
- Adenocarcinoma
(metabolism, pathology)
- Biomarkers, Tumor
(metabolism)
- CDX2 Transcription Factor
- Cell Count
- Diagnosis, Differential
- Homeodomain Proteins
(metabolism)
- Humans
- Immunoenzyme Techniques
- Intermediate Filament Proteins
(metabolism)
- Keratin-20
- Keratin-7
- Keratins
(metabolism)
- Paranasal Sinus Neoplasms
(classification, metabolism, pathology)
- Trans-Activators
|